Celltrion
068270.KS
#724
Rank
โ‚ฌ26.35 B
Marketcap
128,60ย โ‚ฌ
Share price
0.05%
Change (1 day)
-2.19%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total assets

Total assets on the balance sheet as of September 2024 : โ‚ฌ14.96 Billion

According to Celltrion 's latest financial reports the company's total assets are โ‚ฌ14.96 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Celltrion - Total assets on balance sheet (from 2007 to 2024)

Total assets by year

Year Total assets Change
2022-12-31โ‚ฌ4.35 B3.45%
2021-12-31โ‚ฌ4.21 B12.08%
2020-12-31โ‚ฌ3.75 B26.09%
2019-12-31โ‚ฌ2.97 B8.62%
2018-12-31โ‚ฌ2.74 B6.52%
2017-12-31โ‚ฌ2.57 B13.23%
2016-12-31โ‚ฌ2.27 B10.68%
2015-12-31โ‚ฌ2.05 B17.88%
2014-12-31โ‚ฌ1.74 B28.3%
2013-12-31โ‚ฌ1.35 B7.68%
2012-12-31โ‚ฌ1.26 B35.02%
2011-12-31โ‚ฌ0.93 B21.27%
2010-12-31โ‚ฌ0.77 B127.3%
2009-12-31โ‚ฌ0.33 B17.94%
2008-12-31โ‚ฌ0.28 B532.71%
2007-12-31โ‚ฌ45.43 M